(Madera, California) – Valley Children’s Healthcare, in partnership with The Innovation Lab and OrthoPediatrics, will host the third annual Pediatric Innovation Showcase on Thursday, May 18. The virtual gathering will allow participants to hear directly from cutting-edge companies that are advancing products to solve big problems for the smallest patients and their families.
Pediatric Innovation Showcase
Thursday, May 18
10 – 11 a.m. (PST)
Location: Virtual
No cost to participate
“Valley Children’s exists today because of the innovative thinking of our five founding mothers when, in the late 1940s, they imagined a pediatric hospital for kids right here in the Central Valley,” says Valley Children’s Healthcare President and CEO Todd Suntrapak. “Imagination, ‘what is possible’ thinking and perseverance were the hallmarks of innovation then - and they remain a fundamental part of Valley Children’s today.”
A few of the companies to be showcased include:
Accelera
Watching a child who has Cerebral Palsy open their closed hand for the first time or seeing a 3-year-old walk for the first time is truly emotional. Accelera is bringing to market the world’s first wearable stochastic resonance (SR) therapy device for people who experience neurological deficits. Their product, the SR-100, sends a signal in the form of gentle mechanical stimuli (i.e., vibrations or resonance), which aids the body’s proprioceptive and sensorimotor system. If the body is not producing signals strong enough to trigger the brain to cause correct movement, SR primes the neurons, so they do trigger the brain. The technology simply assists with the body’s natural neurological function.
Brightline
Brightline is the first virtual behavioral health solution built specifically to care for children, teenagers and their families across a broad range of needs. With multidisciplinary care teams, evidence-based programs and a family-focused approach, Brightline brings care to families across the country, right when and where they need it.
Cognoa
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable earlier and more equitable access to care that improves the lives and outcomes of children and families. Cognoa’s first product is the first and only FDA-authorized diagnostic that gives more providers the ability to diagnose or rule out autism in children ages 1.5 to 6 years. A remote, digital solution, Canvas Dx equips providers to act rapidly upon first developmental concern and make informed decisions on next steps. With its responsible AI trained on diverse data across race, gender and socioeconomic status, Canvas Dx introduces an objective, equitable diagnostic approach that helps avoid the biases and disparities prevalent in autism diagnostic processes.
In October of 2019, Valley Children’s launched a partnership with The Innovation Institute, a national, independent medical product incubator and healthcare services provider, to spark innovation across the health network. The Institute’s Innovation Lab is staffed with scientists, doctors and commercialization experts who evaluate ideas, build prototypes, protect them, license them and then take them to market directly or through industry partners. Valley Children’s innovation program, known as George’s Idea Lab, operates as part of The Innovation Lab.
To learn more about the Pediatric Innovation Showcase and to register, visit http://innovationlabshowcase.com/.